Inflammatory response in preterm infants is induced early in life by oxygen and modulated by total parenteral

Pascal M Lavoie1, Jean-Claude Lavoie, Carla Watson

  • 1Division of Neonatology, Children's and Women's Health Centre of British Columbia, University of British Columbia, Vancouver, BC, Canada.

Pediatric Research
|August 13, 2010
PubMed

Insights

Parenteral multivitamins (MVP) coadministered with lipid emulsion (LIP) in total parenteral nutrition (TPN) may prevent inflammation. Protecting LIP from light significantly reduced inflammatory markers in premature infants, regardless of oxygen exposure.

Area of Science:

  • Neonatal nutrition and inflammation
  • Oxidative stress in premature infants
  • Parenteral nutrition complications

Background:

  • Intravenous lipid emulsion (LIP) can be a source of oxidants, potentially triggering inflammation.
  • Coadministration of parenteral multivitamins (MVP) with LIP has been shown to prevent lipid peroxidation in light-exposed total parenteral nutrition (TPN).
  • The impact of TPN administration on systemic inflammation, particularly concerning oxygen exposure, requires further investigation.

Purpose of the Study:

  • To investigate whether the TPN administration method influences systemic inflammation in premature infants.
  • To determine if oxygen exposure modulates systemic inflammation in infants receiving different TPN regimens.
  • To assess the role of light protection for lipid emulsions in mitigating inflammatory responses.

Main Methods:

  • Premature infants were assigned to three TPN groups: control (MVP with light-exposed amino acids/dextrose, LIP separate), LIP+MVP light-exposed (LE), and LIP+MVP light-protected (LP).
  • Plasma IL-6 and IL-8 levels, and whole blood glutathione redox potential (E) were measured.
  • Data were analyzed based on oxygen exposure (FiO2 <0.25 vs. ≥0.25) using ANOVA.

Main Results:

  • Cytokine levels (IL-6, IL-8) positively correlated with FiO2 and glutathione redox potential (E).
  • High FiO2 increased cytokine levels in the control group.
  • In the LE and LP groups, inflammatory markers remained unaffected by oxygen exposure, indicating a protective effect of MVP coadministration with LIP, especially when light-protected.

Conclusions:

  • The formulation of TPN admixtures significantly impacts the systemic inflammatory response to oxidant stress.
  • Protecting lipid emulsions from light during TPN administration may mitigate oxygen-induced inflammatory responses in premature infants.
  • Careful consideration of TPN composition and light exposure is crucial for managing inflammation in vulnerable neonates.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...